2023 BioCap Conference

 

Applications have been accepted from companies seeking or will soon be seeking funding.
If selected, you will present your company overview, funding request, and funding needs to a panel of online investors during an 8-minute 'pitch' at 9.30am on Tuesday 26th September. 

Investor Dinner 
Taking place on the evening of Wednesday 27th September at Alderley Park Conference Centre from 6.30 pm, the BioCap Investor Dinner provides an opportunity to build valuable connections ahead of the BioCap Conference. Join Bionow, investors and companies seeking investment for an informal evening of drinks, dinner and networking.
Tickets are limited, so if you would like to attend please select the delegate pass and investor dinner ticket below.

BioCap Conference 
The BioCap Conference provides a unique meeting place connecting life sciences businesses, researchers and investors. Join us in navigating the life sciences funding landscape and identifying the life science investment opportunities that will advance and support the success of your business. Get investor insights, hear from experts, hear about exciting pre-spin-out investment opportunities from the region's universities, get industry perspectives, network with peers and investors and discuss future collaborations in one-to-one partnering meetings.
 
BioCap helps your business to realise its full potential, whatever your funding requirements are.
PLUS: The top three pitches from the Digital Pitching Competition selected by the judging panel will be played at the conference and the winner will also be announced on the day.

For more information on exhibitor opportunities, please click here.
 
For sponsorship opportunities please contact Jesse Gray at jesse.gray@bionow.co.uk


 
2023 investors attending:

Future Planet Capital, Northern Gritstone, Angel investors, Mercia Ventures, Perscitus LLP, Catapult Ventures, Downing Healthcare Ventures, Oyster Venture Partners, Peel Hunt, ACF Investors, Northstar Ventures, KTN, Eos Advisory, Hadean Ventures, British Patient Capital, Deepbridge Capital, DSW Ventures, Bamburgh Capital, Praetura Ventures, Abbvie ventures - corporate VC, British Business Bank
CRSI, Science Angel Syndicate, Ascension Life Fund, Minerva Business Angels, SFC Capital, o2h Ventures, LYVA Labs, Ignite Capital Partners, and more coming.........